Epidemiology and antifungal susceptibility patterns of Candida species in tertiary hospitals: Update on regional trends
DOI:
https://doi.org/10.33448/rsd-v10i4.14462Keywords:
Amphotericin B; Fluconazole; Yeasts; Diagnosis; Polymerase chain reaction.Abstract
Trends in epidemiology and antifungal susceptibility of Candida species in Brazil between 2019–2020 are reported. A total of 22 isolates diagnosed from candidemia episodes were analyzed. Candida species were identified by specie specific primer and/or sequencing of 28S rDNA. Antifungal susceptibility was determined by CLSI method. C. tropicalis accounted for 11 (50%) cases followed by C. albicans (n=5, 22.73%), C. parapsilosis (n=4, 18.19%), Issatchenkia orientalis (n= 1, 4.54%), and Saccharomyces cerevisiae (n= 1, 4.54%). All Candida isolates were susceptible to amphotericin B and micafungin, and one was dose-dependent to anidulafungin. Eight of 20 Candida isolates were resistant to fluconazole and four sensitive doses dependent. Sixteen of 20 Candida isolates were resistant to voriconazole, and one resistant and one sensitive dose-dependent on caspofungin. Besides, the respective MIC50 and MIC90 values were calculated with fluconazole (MIC50 and MIC90 of 4 and 64µg/mL, respectively) and voriconazole (MIC50 and MIC90 of 16µg/mL) showing the lowest potencies. The spread of fluconazole-resistant in one of major concerns, especially to C. tropicalis. The high use of antifungal drug may be a possible cause related to this scenario. Thus, the susceptibility profile test may be used to know the best way to introduce appropriateness empirical antibiotics therapy. Changing trends in incidence and antifungal susceptibility patterns of six Candida species causing candidemia in Kuwait between 2006–2017 are reported. A total of 2075 isolates obtained from 1448 patients were analyzed. Identity of Candida species isolates was determined by phenotypic methods and confirmed by PCR amplification/PCR-sequencing of rDNA and/or MALDI-TOF MS. Antifungal susceptibility was determined by Etest. C. albicans accounted for 539 (37.22%) cases followed by C. parapsilosis (n = 502, 34.67%), C. tropicalis (n = 210, 14.5%), C. glabrata (n = 148, 10.22%), C. krusei (n = 27, 1.81%) and C. dubliniensis (n = 22, 1.5%). The comparative percent distribution of Candida species causing candidemia between 2006–2011 and 2012–2017 was as follows: C. albicans 41.8% and 33.1%, C. parapsilosis complex 32.01% and 37.04%, C. tropicalis 13.59% and 15.31%, and C. glabrata 8.77% and 11.51%, C. krusei 2.0% and 1.7%, and C. dubliniensis 1.75 and 1.3%, respectively. Three of 371 C. albicans isolates during 2006–2011 and five of 363 during 2012–2017 were resistant to fluconazole. Among C. parapsilosis isolates, one of 310 during 2006–2011 and 21 of 446 during 2012–2017 were resistant to this drug. Furthermore, at an epidemiologic cutoff value (ECV) of ≤0.5 μg/ml, 70.1% C. albicans isolates were wild-type for fluconazole during 2006–2011 as compared to 58.1% during 2012–2017. Likewise, at an ECV of ≤2 μg/ml, 98.0% of C. parapsilosis isolates were wild-type during 2006–2011 as compared to 93.4% during 2012–2017. Clonal spread of fluconazole-resistant C. parapsilosis in one major hospital was documented. An 8.8% shift in favor of non-albicans Candida species with concomitant increase in MICs between the two periods preludes emergence of fluconazole-resistant candidemia cases in Kuwait.Changing trends in incidence and antifungal susceptibility patterns of six Candida species causing candidemia in Kuwait between 2006–2017 are reported. A total of 2075 isolates obtained from 1448 patients were analyzed. Identity of Candida species isolates was determined by phenotypic methods and confirmed by PCR amplification/PCR-sequencing of rDNA and/or MALDI-TOF MS. Antifungal susceptibility was determined by Etest. C. albicans accounted for 539 (37.22%) cases followed by C. parapsilosis (n = 502, 34.67%), C. tropicalis (n = 210, 14.5%), C. glabrata (n = 148, 10.22%), C. krusei (n = 27, 1.81%) and C. dubliniensis (n = 22, 1.5%). The comparative percent distribution of Candida species causing candidemia between 2006–2011 and 2012–2017 was as follows: C. albicans 41.8% and 33.1%, C. parapsilosis complex 32.01% and 37.04%, C. tropicalis 13.59% and 15.31%, and C. glabrata 8.77% and 11.51%, C. krusei 2.0% and 1.7%, and C. dubliniensis 1.75 and 1.3%, respectively. Three of 371 C. albicans isolates during 2006–2011 and five of 363 during 2012–2017 were resistant to fluconazole. Among C. parapsilosis isolates, one of 310 during 2006–2011 and 21 of 446 during 2012–2017 were resistant to this drug. Furthermore, at an epidemiologic cutoff value (ECV) of ≤0.5 μg/ml, 70.1% C. albicans isolates were wild-type for fluconazole during 2006–2011 as compared to 58.1% during 2012–2017. Likewise, at an ECV of ≤2 μg/ml, 98.0% of C. parapsilosis isolates were wild-type during 2006–2011 as compared to 93.4% during 2012–2017. Clonal spread of fluconazole-resistant C. parapsilosis in one major hospital was documented. An 8.8% shift in favor of non-albicans Candida species with concomitant increase in MICs between the two periods preludes emergence of fluconazole-resistant candidemia cases in Kuwait.
References
Asadzadeh, M. et al. (2009). Rapid molecular differentiation and genotypic heterogeneity among Candida parapsilosis and Candida orthopsilosis strains isolated from clinical specimens in Kuwait. Journal of Medical Microbiol. 58(1), 745-52.
An, S. F., & Fleming, K. A. (1991). Removal of inhibitors of the polymerase chain reaction from formalin fixed, paraffin-wax embedded tissues. Journal of Clinical Pathology, 44(11), 924-927.
Berkow, E. L., & Lockhart, S. R. (2017). Fluconazole resistance in Candida species: A current perspective. Infection and Drug Resistance, 10, 237–245.
Becton Dickinson GmbH. (2014). Instruções de utilização – meios em placas prontos a usar: BDTM CHROMagarTM Candida Medium.
Beyda, N. D., et al. (2013). Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species, Diagnostic Microbiology and Infectious Disease, 77(4), 324-6.
Bilir, S. P., Ferrufino, C. P., Pfaller, M. A., & Munakata, J. (2015). The economic impact of rapid Candida species identification by T2Candida among high-risk patients. Future Microbiology, 10(7), 1133-44.
Clinical and Laboratory Standards Institute (CLSI) (2008). Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, 3rd ed. CLSI document M27-A3. CLSI, Wayne, PA.
Clinical and Laboratory Standards Institute (CLSI) (2012). Reference method for broth dilution antifungal susceptibility testing of yeasts; CLSI document M27-S4. CLSI, Wayne, PA.
Da Costa, V. G. et al. (2014). Nosocomial bloodstream Candida infections in a tertiary-care hospital in South Brazil: A 4-year survey. Mycopathologia, 178, 243–250.
Day, A. M., McNiff, M. M., da Silva, D. A., Gow, N. A.R., & Quinn, J. (2018). Hog1 Regulates Stress Tolerance and Virulence in the Emerging Fungal Pathogen Candida auris. MSphere, 24, 3-5.
Drummond, L. J. et al. (2003). Changes in sensitivity patterns to selected antibiotics in Clostridium difficile in geriatric in-patients over an 18-month period. Journal of Medical Microbiology, 52, 259–263.
Fagan, R. P. et al. (2013). Incidence trends in pathogen-specific central line-associated bloodstream infections in US intensive care units, 1990-2010. Infection Control & Hospital Epidemiology, 34(9), 893-9.
Van De Groep, K. et al. (2018). Development and first evaluation of a novel multiplex real-time PCR on whole blood samples for rapid pathogen identification in critically ill patients with sepsis. European Journal of Clinical Microbiology & Infectious Diseases, 37(7), 1333-1344.
Inácio, C. P. et al. (2016). Experimental white piedra: a robust approach to ultrastructural analysis, scanning electron microscopy and etiological discoveries. Experimental Dermatology, 25(1), 79-81.
Kathuria, S., et al. (2015). Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method. Journal of Clinical Microbiology, 53(6), 1823-30.
Kullberg, B. J., & Arendrup, M. C. (2015). Invasive Candidiasis. New England Journal of Medicine, 373(15), 1445-56.
Kurtzman, C. P., & Robnett C. J. (1997). Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5’end of the large-subunit (26S) ribosomal DNA gene. Journal of Clinical Microbiology, 35, 1216-1223.
Li, Y. L., Leaw, S. N., Chen, J. H. et al. (2003). European Journal of Clinical Microbiology & Infectious Diseases, 22, 693.
Lortholary, O. et al. (2011). Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrobial Agents and Chemotherapy, 55(2), 532-8.
Pereira, A. S. et al. (2018). Metodologia da pesquisa cientifica. UFSM.
Rangel-Frausto, M. S. et al. (1999). National Epidemiology of Mycoses Survey (NEMIS): Variations in Rates of Bloodstream Infections Due to Candida Species in Seven Surgical Intensive Care Units and Six Neonatal Intensive Care Units. Clinical Infectious Diseases, 29(2), 253–258.
Román, E., Alonso-Monge, R., Miranda, A., & Pla, J. (2015). The Mkk2 MAPKK Regulates Cell Wall Biogenesis in Cooperation with the Cek1-Pathway in Candida albicans. PLoS One, 21, 1-7.
Sambrook, J., Fritch, E. F., & Maniatis, T. (1989). Molecular cloning: A Laboratory Manual. (2a ed.), Cold Spring Harbor Laboratory Press.
Sharafutdinov, I. S. et al. (2020). Increasing Susceptibility of Drug-Resistant Candida albicans to Fluconazole and Terbinafine by 2(5H)-Furanone Derivative. Molecules, 25(3), 642.
Sadrossadati, S. Z. et al. (2018). Phenotypic and genotypic characterization of Candida species isolated from candideamia in Iran. Current Medical Mycology, 4(2), 14-20.
Silva, J. J. D. et al. (2018). Candida species biotypes in the oral cavity of infants and children with orofacial clefts under surgical rehabilitation. Microbial Pathogenesis, 124, 203-215.
Stewart, B. W., & Wild, C. P. (editors) (2014). World cancer report 2014. International Agency for Research on Cancer – IARC.
Yang, H. P., Tsang, P. C., & Tsang, P. W. (2014). Melatonin inhibits biofilm formation in Candida parapsilosis. Journal De Mycologie Medicale, 24(4), 360-1.
Wisplinghoff, H. et al. (2004). Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study. Clinical Infectious Diseases, 39(3), 309–317.
Zervou, F. N., Zacharioudakis, I. M., Kurpewski, J., & Mylonakis, E. (2017). T2 Magnetic Resonance for Fungal Diagnosis. Methods in molecular biology, 1508, 305-319.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Cicero Pinheiro Inácio; Fernanda Gomes Beserra; Cynthia Regina Pedrosa Soares; Luciana Maria Delgado Romaguera; Paulo Sergio Ramos de Araújo; Maria Daniela Silva Buonafina; Luiz Nascimento Araújo Neto; Dalmir Cavalcanti dos Santos; Rejane Pereira Neves
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
